Key facts
- This page summarizes MILLENNIUM MANAGEMENT LLC's Form 4 filing for Sensei Biotherapeutics, Inc. (SNSE).
- 17 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 May 2026, 16:24.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
Purchase
Purchase
Purchase
Purchase
Purchase
Purchase
Purchase
Purchase
Purchase
Purchase
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Purchase
Purchase
Purchase
Purchase
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Purchase
Purchase
Purchase
Purchase
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Additional SEC filing notes
Section 16 status
MILLENNIUM MANAGEMENT LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
Represents volume-weighted average price ("VWAP") of purchases of 26 shares of common stock ("Common Stock"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the "Company") on April 2, 2026 at prices ranging from $32.90 to $33.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting persons will provide full information regarding the number of shares purchased or sold by the reporting person at each separate price within each range represented by a VWAP disclosed herein.
Footnote F2
In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2.
Footnote F3
The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any.
Footnote F4
Represents VWAP of purchases of 1,276 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.97 to $34.90.
Footnote F5
Represents VWAP of purchases of 701 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $35.4481 to $35.91.
Footnote F6
Represents VWAP of sales of 3,099 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $30.1332 to $31.1212.
Footnote F7
Represents VWAP of sales of 1,265 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $31.21 to $32.15.
Footnote F8
Represents VWAP of sales of 1,794 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $32.22 to $33.1251.
Footnote F9
Represents VWAP of sales of 374 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.23 to $33.45.
Footnote F10
Represents VWAP of sales of 1,134 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $34.40 to $35.25.
Footnote F11
Represents purchases of 1,104 shares of the Company's Common Stock on April 6, 2026 at $31.02 per share.
Footnote F12
Represents VWAP of sales of 1,214 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $30.64 to $31.345.
Footnote F13
Represents VWAP of sales of 45 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $31.80 to $32.17.
Footnote F14
Represents VWAP of purchases of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share.
Footnote F15
Represents VWAP of sales of 2,115 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $28.5071 to $29.3167.
Footnote F16
Represents VWAP of sales of 205 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $29.695 to $30.50.
Footnote F17
Represents VWAP of sales of 4,423 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $30.9852 to $31.813.
Footnote F18
Represents VWAP of sales of 300 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $32.0625 to $32.615.
Footnote F19
Represents sales of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share.
SEC remarks
Assuming, without conceding, the application of Section 16(b) of the Securities Exchange Act of 1934, the reporting persons have disgorged to the Company all amounts that could be deemed profit realized by them from the transactions in the Company's Common Stock reported on this Form 4 and the other two statements on Form 4 filed by Millennium Management LLC on the same date.